4-(2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-MORPHOLINE structure 
             | 
        Common Name | 4-(2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL)-MORPHOLINE | ||
|---|---|---|---|---|
| CAS Number | 864754-10-9 | Molecular Weight | 363.25600 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C19H30BNO5 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
| Name | 4-[2-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl]morpholine | 
|---|---|
| Synonym | More Synonyms | 
| Molecular Formula | C19H30BNO5 | 
|---|---|
| Molecular Weight | 363.25600 | 
| Exact Mass | 363.22200 | 
| PSA | 49.39000 | 
| LogP | 1.64330 | 
| 
                                        
                                        
                                        
                                        
                                         ~%  
                                            4-(2-[2-METHOXY... CAS#:864754-10-9  | 
                                
| Literature: HUTCHISON MEDIPHARMA LIMITED; Su, Wei-Guo; Deng, Wei; Ji, Jianguo Patent: US2014/121200 A1, 2014 ; Location in patent: Paragraph 0176; 0179; 0180 ; | 
| 4-{2-[2-METHOXY-4-(4,4,5,5-TETRAMETHYL-[1,3,2]DIOXABOROLAN-2-YL)-PHENOXY]-ETHYL}-MORPHOLINE | 
| Morpholine,4-[2-[2-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]ethyl] |